Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Imunon, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 22 | 18 | −4 |
| Shares | 419.9K | 335.5K | −84.4K (−20.1%) |
| Value | $285.9K | $539.4K | +$253.5K (+88.7%) |
New holders (2)
Institutions that held Imunon, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Colony Group, LLC | 35,000 | $46.0K | 0.00% |
| Citigroup Inc | 46 | $75 | 0.00% |
Sold out (6)
Institutions that held Imunon, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Citadel Advisors LLC | 29,628 | $20.1K |
| HRT Financial LP | 28,569 | $19.0K |
| Virtu Financial LLC | 25,860 | $18.0K |
| Susquehanna International Group, LLP | 22,864 | $15.5K |
| Two Sigma Securities, LLC | 13,841 | $9.41K |
| Bank of America Corp | 137 | $93 |